Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?

Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, LeVine H.

Amino Acids. 2002;23(1-3):87-93.

PMID:
12373522
2.

Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC.

J Neurosci. 2000 May 15;20(10):3606-11.

3.

Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice.

Walker LC, Callahan MJ, Bian F, Durham RA, Roher AE, Lipinski WJ.

Peptides. 2002 Jul;23(7):1241-7.

PMID:
12128081
4.

The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.

Kuo YM, Beach TG, Sue LI, Scott S, Layne KJ, Kokjohn TA, Kalback WM, Luehrs DC, Vishnivetskaya TA, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Weller RO, Roher AE.

Mol Med. 2001 Sep;7(9):609-18.

5.

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

Götz J, Schild A, Hoerndli F, Pennanen L.

Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.

PMID:
15465275
7.

Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein.

Bates KA, Fonte J, Robertson TA, Martins RN, Harvey AR.

Neuroscience. 2002;113(4):785-96.

PMID:
12182886
8.
10.

Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.

van Groen T, Kiliaan AJ, Kadish I.

Neurobiol Dis. 2006 Sep;23(3):653-62. Epub 2006 Jul 10.

PMID:
16829076
11.

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

Neuroscientist. 2007 Feb;13(1):38-48. Review.

PMID:
17229974
12.

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM.

Neurobiol Aging. 2003 Dec;24(8):1063-70.

PMID:
14643377
13.

Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM.

J Neurosci. 2002 Dec 1;22(23):10083-7.

14.

Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.

Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ.

Neurobiol Aging. 2006 Mar;27(3):377-86. Epub 2005 May 31.

PMID:
15927307
15.

Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG.

J Neurosci. 2004 Apr 14;24(15):3801-9.

16.

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM.

Science. 2002 Mar 22;295(5563):2264-7.

17.

Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.

Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L, Hamel E.

Neuroscience. 2005;132(1):73-86.

PMID:
15780468
18.

Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.

Klingner M, Apelt J, Kumar A, Sorger D, Sabri O, Steinbach J, Scheunemann M, Schliebs R.

Int J Dev Neurosci. 2003 Nov;21(7):357-69.

PMID:
14599482
19.

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.

Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T.

Neurobiol Dis. 2005 Dec;20(3):814-22. Epub 2005 Aug 24.

PMID:
16125396
20.

Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease.

Richardson JC, Kendal CE, Anderson R, Priest F, Gower E, Soden P, Gray R, Topps S, Howlett DR, Lavender D, Clarke NJ, Barnes JC, Haworth R, Stewart MG, Rupniak HT.

Neuroscience. 2003;122(1):213-28.

PMID:
14596862

Supplemental Content

Support Center